[2100 Grafts to Frontal Third | Dutasteride + Oral Minoxidil Stack | SMP + PRP | 42 Years Old Transplants 6/8/2025
A 42-year-old had 2,100 grafts transplanted to the frontal third of the scalp, using treatments like Dutasteride, oral Minoxidil, ketoconazole shampoo, dermarolling, and PRP. They plan to add RU58841 and have scheduled SMP to improve cosmetic results.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity I cry every day, everything is very depressing
A user is experiencing hair loss despite using dutasteride and oral minoxidil, feeling hopeless and considering a hair system. They are advised to try ketoconazole, seek a second opinion from a dermatologist, and consider treatments like finasteride, RU58841, and hair transplants.
community Doctor said exosome therapy is so painful that one of his patients tried to choke him mid-session
The user visited a dermatologist for hair loss and was prescribed finasteride and minoxidil tablets, along with a caffeine hair serum. They decided against painful and costly treatments like PRP and exosome therapy, opting instead to stick with medications and possibly accept going bald.
community My temples after 2.5 months on oral fin/dut, ketoconazole shampoo, minoxidil, tretinoin and dermarolling
The user shared progress pictures showing improved hair growth at the temples after 2.5 months using oral finasteride/dutasteride, ketoconazole shampoo, minoxidil, tretinoin, and dermarolling. The user reported no side effects from the medications and noted inconsistent microneedling.
community 2.5mg Oral Minox per day, Derma roll 1x/week, Ketoconazole Shampoo 3x/week. 2 month progress. Currently have Oral Dut and Min on the way in the mail. We just might make it.
The conversation is about hair loss treatment progress using 2.5mg oral Minoxidil daily, derma rolling weekly, and Ketoconazole shampoo thrice weekly, with plans to add oral Dutasteride. Users discuss the potential benefits and timing of using Dutasteride for hair recovery.
community 6,5 months on oral finasteride 1mg, oral minoxidil 5mg daily, with ketokonazole shampoo and dermarolling every other week.
Significant hair regrowth was achieved using oral finasteride 1mg, oral minoxidil 5mg daily, ketoconazole shampoo, and dermarolling. It is advised to continue this regimen for 12-18 months before considering any changes.
Related Research
6 / 6 results
research Experimental and early investigational drugs for androgenetic alopecia
This review discusses current and emerging therapeutic strategies for androgenetic alopecia, noting limited evidence but suggesting areas such as prostaglandin analogs, PRP, and progenitor cell therapies as promising future directions.
research Medical Therapy for Female Pattern Hair Loss (FPHL)
This commentary explores the challenges and considerations in treating female pattern hair loss, with no new clinical findings reported.
research Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA
This pilot study found that a novel regimen including NuH Hair led to significant hair growth in male patients with androgenic alopecia, regardless of atopy status, with quicker results when additional treatment components were used.
research Female pattern hair loss
Female pattern hair loss, common in women, can be treated with various methods like minoxidil, anti-androgen treatments, and light therapy, but early intervention and realistic expectations are crucial.
research Faculty Opinions recommendation of Promising therapies for treating and/or preventing androgenic alopecia.
There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.
research Treat androgenetic alopecia with antiandrogens, as well as other pharmacological and non-pharmacological interventions
This review discusses current treatment options for androgenetic alopecia, noting that most lack robust evidence for efficacy and safety, highlighting the need for more comprehensive studies.